Social History and Glaucoma Progression
OCT
1 other identifier
observational
1,584
1 country
1
Brief Summary
The objective of this study is to predict of glaucoma progression. By imaging of the retinal nerve fiber layer RNFL, optic nerve head (ONH) and macular measurements using spectral-domain OCT (SD-OCT) instruments
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 20, 2024
CompletedFirst Posted
Study publicly available on registry
May 30, 2024
CompletedMay 30, 2024
May 1, 2024
6 months
May 20, 2024
May 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
OCT structural parameters
RNFL in (um), ONH in (um), as well as the inner macula thickness (in um) using spectral domain OCT
6 months
Study Arms (1)
Primary Open Angle Glaucoma
1. Patients older than 18 years of age with primary open-angle glaucoma (POAG) 2. POAG diagnosed on the basis of IOP measurements more than 21 mmHg, Open angle on gonioscopy (Grade 3 or 4 on Schaffer grading system for angle width), glaucomatous visual field defects consistent with glaucomatous optic disc changes. 3. Eyes with baseline macular and ONH OCT images and ONH photographs of adequate quality and r performed within 6 months of each other were selected
Eligibility Criteria
Patients older than 18 years of age with primary open-angle glaucoma (OAG)
You may qualify if:
- IOP measurements more than 21 mmHg
- Open angle on gonioscopy (Grade 3 or 4 on Schaffer grading system for angle width)
- Glaucomatous visual field defects consistent with glaucomatous optic disc changes.
- Eyes with baseline macular and ONH OCT images and ONH photograps
You may not qualify if:
- Participants with significant retinal disease.
- non-glaucomatous optic neuropathy.
- anomalous discs
- any retinal pathology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine
Asyut, 71515, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 20, 2024
First Posted
May 30, 2024
Study Start
January 1, 2022
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
May 30, 2024
Record last verified: 2024-05